摘要
目的心房纤颤是临床常见的心律失常,药物治疗是其治疗的重要部分。文中观察氯沙坦(Losartan)联合胺碘酮(Amiodarone)治疗心房纤颤(简称房颤)的临床效果,并探讨其机制与安全性。方法将43例房颤患者随机分为观察组27例、对照组16例,观察组给予胺碘酮和氯沙坦,对照组则单用胺碘酮,治疗共6个月。结果经过治疗,观察组治疗结束后随访6月窦性心律维持明显高于对照组,左心房内径明显低于对照组,左心房射血分数明显高于对照组,有显著性差异(P<0.05)。2组患者不良反应发生情况类似,患者均可耐受。结论氯沙坦联合胺碘酮治疗房颤,疗效显著,作用持久,无严重不良反应发生,可以有效安全地应用于临床,疗效优于单独使用胺碘酮。
Objective Atrial fibrillation is a common arrhythmia in clinic,which is mainly treated by drugs.The present study was to observe the effect of Amiodarone combined with Angiotensin ⅡReceptor Blocker(ARB)-Losartan on atrial fibrillation(AF).Methods Forty-three consecutive patients with persistent atrial fibrillation were randomly divided into two groups: Amiodarone-treated group(Group A,16 patients),and Amiodarone-Losartan-treated group(Group B,27 patients).After one month′s oral medication,patients′ left atrial diameter(LAD),left atrial ejection fraction(LAEF) as well as general condition were determined during their six months′ follow-up.Results Among the 43 patients completed the clinical observation,LAD was significantly larger in Group A than that in Group B(P0.05),while the LAEF in Group A was significantly lower than that in Group B.Obviously the ratio of successful sinus rhythm maintenance in Group B was higher than that in Group A(P0.05).Conclusion The prescription of Amiodarone plus Losartan could reverse left atrium expansion,reverse atrial fibrillation,and maintain sinus rhythm more effectively than single oral Amiodarone.
出处
《医学研究生学报》
CAS
2010年第11期1179-1181,共3页
Journal of Medical Postgraduates
关键词
胺碘酮
氯沙坦
心房纤颤
Atrial fibrillation
Amiodarone
Losartan